TW201014850A
(en)
|
2008-09-25 |
2010-04-16 |
Takeda Pharmaceutical |
Solid pharmaceutical composition
|
JP5535931B2
(ja)
|
2008-10-27 |
2014-07-02 |
武田薬品工業株式会社 |
二環性化合物
|
WO2010076884A1
(ja)
|
2008-12-29 |
2010-07-08 |
武田薬品工業株式会社 |
新規縮合環化合物およびその用途
|
EP2440541A1
(en)
|
2009-06-09 |
2012-04-18 |
Takeda Pharmaceutical Company Limited |
Novel fused cyclic compound and use thereof
|
EA201270204A1
(ru)
|
2009-07-28 |
2012-08-30 |
Такеда Фармасьютикал Компани Лимитед |
Таблетка
|
SI2464232T1
(sl)
|
2009-08-10 |
2016-03-31 |
Samumed, Llc. |
Indazolovi inhibitorji signalne poti WNT in njihova terapevtska uporaba
|
US20110112158A1
(en)
*
|
2009-11-11 |
2011-05-12 |
David Robert Bolin |
Benzisoxazole analogs as glycogen synthase activators
|
WO2011084486A1
(en)
|
2009-12-21 |
2011-07-14 |
Epitherix, Llc |
1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
SG185759A1
(en)
|
2010-04-27 |
2012-12-28 |
Takeda Pharmaceutical |
Bicyclic compound derivatives and their use as acc inhibitors.
|
SG186223A1
(en)
|
2010-06-16 |
2013-01-30 |
Takeda Pharmaceutical |
Crystal of amide compound
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
WO2012036293A1
(ja)
|
2010-09-17 |
2012-03-22 |
武田薬品工業株式会社 |
糖尿病治療剤
|
EP2649062B1
(en)
|
2010-11-30 |
2015-04-08 |
Takeda Pharmaceutical Company Limited |
Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc)
|
KR20140015371A
(ko)
|
2011-02-17 |
2014-02-06 |
다케다 야쿠힌 고교 가부시키가이샤 |
광학적 활성 디히드로벤조푸란 유도체 제조 방법
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
CN103929963A
(zh)
|
2011-09-14 |
2014-07-16 |
萨穆梅德有限公司 |
吲唑-3-羧酰胺及其作为WNT/β-CATENIN信号传导通路抑制剂的用途
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
CN103998432A
(zh)
|
2011-10-24 |
2014-08-20 |
武田药品工业株式会社 |
双环化合物
|
JP6129850B2
(ja)
|
2012-01-12 |
2017-05-17 |
武田薬品工業株式会社 |
Mch受容体拮抗剤としてのベンゾイミダゾール誘導体
|
JP6121339B2
(ja)
|
2012-02-13 |
2017-04-26 |
武田薬品工業株式会社 |
芳香環化合物
|
JP6095580B2
(ja)
|
2012-02-13 |
2017-03-15 |
武田薬品工業株式会社 |
芳香環化合物
|
EP2814466B1
(en)
|
2012-02-15 |
2018-12-26 |
Takeda Pharmaceutical Company Limited |
Tablet comprising 1-(4-methoxybutyl)-n-(2-methylpropyl)-n-[(3s,5r)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1h-benzimidazole-2-carboxamide or a salt thereof
|
JP6106179B2
(ja)
|
2012-02-24 |
2017-03-29 |
武田薬品工業株式会社 |
芳香環化合物
|
WO2013147026A1
(ja)
|
2012-03-29 |
2013-10-03 |
武田薬品工業株式会社 |
芳香環化合物
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
RS59668B1
(sr)
|
2012-05-04 |
2020-01-31 |
Samumed Llc |
1h-pirazolo[3,4-b]piridini i njihova terapeutska upotreba
|
EP2848621A4
(en)
|
2012-05-10 |
2016-06-01 |
Takeda Pharmaceutical |
AROMATIC CYCLIC COMPOUND
|
WO2013168760A1
(ja)
|
2012-05-10 |
2013-11-14 |
武田薬品工業株式会社 |
芳香環化合物
|
TWI580444B
(zh)
|
2012-06-05 |
2017-05-01 |
武田藥品工業股份有限公司 |
固態製劑
|
JP2015127299A
(ja)
|
2012-07-19 |
2015-07-09 |
武田薬品工業株式会社 |
固形製剤
|
CN105120862A
(zh)
|
2013-01-08 |
2015-12-02 |
萨穆梅德有限公司 |
Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
|
WO2014142363A1
(en)
|
2013-03-14 |
2014-09-18 |
Takeda Pharmaceutical Company Limited |
Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
CN105358544A
(zh)
|
2013-07-09 |
2016-02-24 |
武田药品工业株式会社 |
杂环化合物
|
WO2015020184A1
(ja)
|
2013-08-09 |
2015-02-12 |
武田薬品工業株式会社 |
芳香環化合物
|
JO3442B1
(ar)
|
2013-10-07 |
2019-10-20 |
Takeda Pharmaceuticals Co |
مضادات ذات نوع فرعي من مستقبل سوماتوستاتين 5 (sstr5)
|
US9346776B2
(en)
|
2014-02-13 |
2016-05-24 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound
|
US9428470B2
(en)
|
2014-02-13 |
2016-08-30 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
CN104151216B
(zh)
*
|
2014-08-22 |
2016-08-17 |
山东铂源药业有限公司 |
一种拉帕替尼侧链的合成方法
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016115272A1
(en)
|
2015-01-13 |
2016-07-21 |
Vanderbilt University |
Benzothiazole and benzisothiazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
ES2882667T3
(es)
|
2015-08-07 |
2021-12-02 |
Bayer Cropscience Ag |
Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas
|
EP3370721A4
(en)
|
2015-11-06 |
2019-05-22 |
Samumed, LLC |
TREATMENT OF OSTEOARTHRITIS
|
GB201604970D0
(en)
|
2016-03-23 |
2016-05-04 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
HUE060797T2
(hu)
|
2016-06-01 |
2023-04-28 |
Biosplice Therapeutics Inc |
Eljárás N-(5-(3-(7-(3-fluorfenil)-3H-imidazo[4,5-c]piridin-2-il)-1H-indazol-5-il)- piridin-3-il)-3-metilbutánamid elõállítására
|
EP3528808B1
(en)
|
2016-10-21 |
2021-10-06 |
BioSplice Therapeutics, Inc. |
Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
|
WO2018085865A1
(en)
|
2016-11-07 |
2018-05-11 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
JOP20180029A1
(ar)
|
2017-03-30 |
2019-01-30 |
Takeda Pharmaceuticals Co |
مركب حلقي غير متجانس
|
JOP20180028A1
(ar)
|
2017-03-31 |
2019-01-30 |
Takeda Pharmaceuticals Co |
مركب ببتيد
|
AR111199A1
(es)
|
2017-03-31 |
2019-06-12 |
Takeda Pharmaceuticals Co |
Compuesto aromático agonista de gpr40
|
WO2018181847A1
(ja)
|
2017-03-31 |
2018-10-04 |
武田薬品工業株式会社 |
芳香環化合物
|
CN110117278B
(zh)
*
|
2018-02-07 |
2022-07-19 |
石家庄以岭药业股份有限公司 |
烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
|
IL277495B1
(en)
|
2018-03-23 |
2024-04-01 |
Carmot Therapeutics Inc |
Modulators of protein-coupled receptors - G
|
AR116019A1
(es)
|
2018-08-27 |
2021-03-25 |
Scohia Pharma Inc |
Derivados de guanidinobenzoilo como inhibidores de enteropeptidasa
|
EP3856339A1
(en)
|
2018-09-24 |
2021-08-04 |
Takeda Pharmaceutical Company Limited |
Gip receptor agonist peptide compounds and uses thereof
|
WO2020067557A2
(en)
|
2018-09-24 |
2020-04-02 |
Takeda Pharmaceutical Company Limited |
Gip receptor agonist peptide compounds and uses thereof
|
KR20220157409A
(ko)
|
2020-03-25 |
2022-11-29 |
다케다 야쿠힌 고교 가부시키가이샤 |
Gip 수용체 작용제 펩티드 화합물 및 이의 용도
|
EP4126921A2
(en)
|
2020-03-25 |
2023-02-08 |
Takeda Pharmaceutical Company Limited |
Qd dosing of gip receptor agonist peptide compounds and uses thereof
|
CN112062754B
(zh)
*
|
2020-09-24 |
2022-06-21 |
深圳市华先医药科技有限公司 |
一种合成Dorzagliatin的中间体的制备方法
|
WO2022078356A1
(zh)
*
|
2020-10-15 |
2022-04-21 |
山东轩竹医药科技有限公司 |
杂芳环类AhR抑制剂
|
CN112300028B
(zh)
*
|
2020-10-27 |
2022-03-11 |
无锡双启科技有限公司 |
一种2-氨基-3-甲氧基-5-溴苯腈的制备方法
|
EP4274824A1
(en)
*
|
2021-01-08 |
2023-11-15 |
IFM Due, Inc. |
Heterobicyclic compounds having an urea or analogue and their compositions for treating conditions associated with sting activity
|
KR20240007251A
(ko)
|
2021-05-13 |
2024-01-16 |
카모트 테라퓨틱스, 인크. |
G-단백질 결합 수용체의 조절제
|
WO2023169456A1
(en)
|
2022-03-09 |
2023-09-14 |
Gasherbrum Bio , Inc. |
Heterocyclic glp-1 agonists
|
WO2023179542A1
(en)
|
2022-03-21 |
2023-09-28 |
Gasherbrum Bio , Inc. |
5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
|
WO2023198140A1
(en)
|
2022-04-14 |
2023-10-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
WO2024112831A1
(en)
*
|
2022-11-22 |
2024-05-30 |
Maze Therapeutics, Inc. |
Inhibitors of solute carrier family 6a member 19 (slc6a19) and methods of use thereof
|
WO2024125602A1
(en)
|
2022-12-15 |
2024-06-20 |
Gasherbrum Bio, Inc. |
Salts and solid forms of a compound having glp-1 agonist activity
|
WO2024131869A1
(en)
|
2022-12-22 |
2024-06-27 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
WO2024138048A1
(en)
|
2022-12-22 |
2024-06-27 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|